quinta-feira, 20 de agosto de 2015

Little tractor for big jobs

 

Harman is a compact mini-tractor designed for use in small fields, big gardens or vineyards. The design brings a new perspective to small tractors that despite their small size, are able to handle great works. To do this, the vehicle was designed with 2 tracks that lead to 1 exit on the body instead of wheels, which made the vehicle fast and small. These tracks absorb impact with a specialized damper system, enabling the driver to work with the utmost comfort. The track structure also makes it possible for the vehicle can be controlled with a joystick instead of a wheel.

The working part of the vehicle exists primarily at the back of the body. The chasis’ front is heavier then the back to balance the weight. The vehicle’s total weight is 60% on the front without its additions and 50% when its loaded or with additions.

Designer: Sinan Anayurt

 

t_01

t_02

t_03

t_04

t_05

IBM and Linux Advancing the Open Source Revolution

 

 

  • By Ross Mauri, General Manager, IBM z Systems on August 20, 2015 | Provided by IBM

“I’ve felt strongly that the advantage of Linux is that it doesn’t have a niche or any special market, but that different individuals and companies end up pushing it in the direction they want…” Linus Torvalds

The wisdom of Linus Torvalds and the magic of the Linux experience he created more than 20 years ago is rooted in a visionary commitment to openness and collaboration that has pushed the boundaries of innovation and transformed whole industries.
For two decades now, Linux has played a major role in a transformation in information technology that has taken us to the brink of a new era, driven by three major disruptors –
big data, cloud and analytics.
Perhaps the greatest impact Linux has had on my company and the information technology industry over the past two decades is the way it has spurred so much innovation through building strong, open ecosystems.

Linux and the growing open source community are demonstrating the value of the collaborative business model. It is clear that no one company alone can spark the magnitude or diversity of the type of innovation we are going to need to keep pace with the rapid changes occurring in the digital/mobile era.

The partnership of IBM and Linux is a great example. Through its commitment to open source technology and an expansive ecosystem of partners, Linux has become the fastest growing operating system in the world, an engine of community innovation and a key part of the enterprise IT infrastructure. As a result, the market for Linux servers, applications, software and operating systems surpassed $57 billion in 2014, almost doubling in the past five years, according to IDC.

For more than 50 years the mainframe has served as the backbone of the global economy. More than half of the world’s transactions run on the mainframe due to its reliability and ultra-secure environment. It now powers 92 of the top 100 banks and 23 of the top 25 airlines around the world. Since being introduced to the mainframe 15 years ago, demand for Linux on the mainframe has grown dramatically, with more than one third of all mainframe clients now using Linux.

But the world is shifting. The mobile world and new app economy are changing the game for businesses, industries and society at large, creating new requirements and expectations that must be addressed. And also creating new opportunities to innovate and differentiate.

In a world where consumer expectations continue to grow, clients demand:

• Delivery at speed with lightning-fast response times, all the time
• Access anytime, anywhere, and from any device, no matter how many users or transactions
• Security for trusted engagement, with personalization through analytics
• And new levels of IT efficiency and agility through cloud for responsiveness

It is clear, we need to take Linux to the next level where it can fully support the future of high-volume, business-critical applications. That is the goal of IBM LinuxONE, a new family of enterprise-grade Linux systems and solutions that combines the flexibility and agility of the open source revolution with the most advanced high-performance engine that underpins enterprise IT. The line of systems provides the capabilities companies need to quickly react to market demands and customer requirements even as volumes increase. It provides unmatched availability to ensure critical systems continue running under any situation. And it provides the most secure Linux system, giving consumers the protection they expect for their data and transactions.

We’ve also dramatically expanded the set of open source software and tools that run on IBM z Systems, providing developers with more flexibility and enabling the development of IT applications with new levels of speed, scale and security. And, because we know that open collaboration across academic, government and corporate partners is key to the advancement of technology, we’re contributing the single largest amount of mainframe code to the open source community and taking additional steps to bolster our already strong commitment to open source innovation. Taken together, all of this represents a quantum leap in open source innovation and a game-changer for the industry.

The growing successes of Linux and the introduction of the LinuxONE portfolio prove the marriage of business-model innovation with technology innovation results in unparalleled choice, freedom and superior performance demanded by businesses and individuals around the world. It is clear, the future belongs to open, flexible, customized, cloud-capable and big data-ready IT systems. Strong, open ecosystems will take us there.

 

A One Stop Shop to Identify Blood Clots

 

 

Thu, 08/20/2015 - 2:30pm

Greg Watry, Digital Reporter

 

The whole body of a rat can be imaged for blood clots with one PET scan (which is overlaid here on an MRI image) using the FBP8 probe. Arrow points to a blood clot. Image: Peter Caravan, PhD

The whole body of a rat can be imaged for blood clots with one PET scan (which is overlaid here on an MRI image) using the FBP8 probe. Arrow points to a blood clot. Image: Peter Caravan, PhDEach year, 795,000 Americans experience a stroke, according to the Centers for Disease Control and Prevention (CDC). Nearly 185,000 of those people have had a previous stroke. It’s estimated strokes cost the U.S. $34 billion in health care services, medications and missed days of work.

According to Peter Caravan, of Massachusetts General Hospital, strokes are caused when a blood clot somewhere in the body breaks off and travels to the brain.

“Blood clots are associated with the leading causes of death and morbidity,” he said at the 250th National Meeting & Exposition of the American Chemical Society. Heart attack, stroke, pulmonary embolism and deep vein thrombosis all occur because of blood clots in the coronary arteries, brain, lungs or legs. “There’s an urgent need to find these clots when they occur,” he said.  

Physicians employ multiple methods to detect blood clots, including ultrasounds on carotid arteries or legs, magnetic resonance imaging to scan the heart and computed tomography for the lungs. But Caravan and his team have developed a new method to detect blood clots with a single scan.

“In my lab, we’ve invented a new molecular probe that, upon injection into a vein, will go travel through the body and find blood clots wherever they’re occurring,” Caravan said.

Called positron emission tomography, the method utilizes a fibrin binding probe, containing copper-64, to search the body for the clot. Caravan called it a “convenient” but “expensive” test, simply involving a puncture of a vein to deliver the probe. “It can replace multiple tests and that’s where we believe there is real value,” said Caravan.

“The cost of the test is appropriate to the clinical decision that is occurring,” he said.

With a half-life of 12.7 hrs, copper-64 clears through the kidneys and whatever remains decays in the body, according to Caravan. A human dosage would be 100 micrograms.

After identifying a clot, different strategies can be employed for clearance, including a thrombectomy, breakdown via a tissue plasminogen activator or prescribing and antithrombotic.

Currently, “we’re compiling the regulatory documents that will allow us to use this probe in (human) patients,” said Caravan. Clinical trials are slated to begin by the end of 2015 or early 2016.

Tested on rodents, the new method yielded results of 97% accuracy.

 

http://www.rdmag.com/articles/2015/08/one-stop-shop-identify-blood-clots